Gilead Sciences EPS Diluted from Extraordinaries (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

147.49 -2.34 (-1.56%) USD | NASDAQ | Feb 24, 10:19

View EPS Diluted from Extraordinaries (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Johnson & Johnson	--
Eli Lilly & Co.	--
Regeneron Pharmaceuticals, Inc.	--
Moderna, Inc.	--